Stockreport

RedHill Biopharma Provides Initial Update from its Opaganib COVID-19 Compassionate Use Program in Israel

Redhill Biopharma Ltd. - American Depositary Shares  (RDHL) 
US:NASDAQ Investor Relations: ir.redhillbio.com/investor-relations
PDF Objective improvement in first two patients treated with opaganib in Israel who have demonstrated measurable clinical improvement within days of treatment initiation, in [Read more]